SEARCH RESULTS

9 RESULTS

Stephen Salloway on Biogen/Eisai Halt Phase 3 Aducanumab Trials

COMMENT It was very disappointing to learn that Biogen plans to close the ENGAGE trial because of lack of efficacy on the interim analysis. We had been eagerly looking forward to the results next year and this came out of the blue. This antibody did not work for ...

Stephen Salloway on Book Review: Neuroimaging in Dementia

COMMENT Neuroimaging in Dementia is a gem of a book, highly recommended for current and future clinicians and clinical researchers interested in the care of patients with cognitive decline. Beautifully illustrated and well-balanced, its intelligent design ...

Current Filters

  • TYPE: Comment x
  • Commentator: Salloway, Stephen x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE